SKP-0141
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SKP-0141, covering 2024-12-18 to 2024-12-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients [Phase 3]